Zimmermann, B., Starke, G., Shaw, D., Elger, B., & Koné, I. (2020). Actionability and scope should determine the extent of counselling for presymptomatic genetic testing. Swiss Medical Weekly, 150(2728), w20274. https://doi.org/10.4414/smw.2020.20274